Please assess the completion status of the following clinical trial:

Trial Title: Use of Corticosteroids in Children With Cellulitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Children Aged 1 month to 18 years~* Hospitalized due to cellulitis~* Patients who have given their written informed consent to participate~Exclusion Criteria:~* Skin chronic diseases~* Immunodeficiency (primary or acquired)~* Chronic use of systemic corticosteroids~* Sepsis~* Varicella~* History of adrenal insufficiency~* Pregnancy or breast feeding~* Uncontrolled diabetes mellitus~* Known hypersensitivity to systemic or topical corticosteroids~* Patient undergoing immunosuppressive therapy for another disease~* Participation in another drug biomedical research~* Any other contraindication for treatment with corticosteroids

- Gender: ALL
- Minimum Age: 1 Month
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- CORTICOSTEROID (Type: EXPERIMENTAL): In addition to standard care for cellulitis, subject will receive intravenous Dexamethasone (8mg/2ml) 0.15 mg/kg/dose every 6 hours for the first 48 hours
- NORMAL SALINE (Type: PLACEBO_COMPARATOR): In addition to standard care for cellulitis, subject will receive normal saline solution administered intravenously using the same volume as the active drug group every 6 hours for the first 48 hours

Based on this trial design, predict the completion outcome and termination type (if applicable).